Damon Cruse

Damon Cruse is an experienced healthcare professional currently serving as a Key Account Manager at Adaptive Biotechnologies Corp., where responsibilities include promoting clonoSEQ in the Academic/Institutional setting and fostering relationships with advocates and key opinion leaders in the Hematology MRD space. Previously, Damon held roles as a Diagnostic Hematology Specialist at Adaptive Biotechnologies, a Specialty Account Representative at Pharmacosmos Therapeutics Inc., and Clinical Oncology Specialist positions at Natera and AstraZeneca, focusing on innovative therapies and diagnostics in oncology and hematology. Early career experience includes promoting immuno-oncology products at Merck & Co. Damon holds a Bachelor's Degree in Health and Biology from Texas A&M University.